-
., M.D., D.V.M.). The applicant should have a Ph.D. in cognitive neuroscience, neuroscience, biomedical engineering, computer science, or a related field. Expertise in analyzing intracranial
-
cancer therapeutics. Experience in cell-based therapeutics is preferred. The Postdoc will develop and optimize novel dendritic cell and T cell therapies against cancers using sophisticated immunogenomic
-
in the last 1-3 years, in a quantitative discipline, such as Computational Biology, Computer Science, Biomedical Engineering, Electrical Engineering, Data science, Physics, Mathematics, Bioinformatics
-
to early phase clinical trials. We collaborate with investigators intramurally (Duke Pharmacology & Cancer Biology, Cell Biology, Biomedical Engineering), and extramurally nationally and internationally
-
Quinn Ostrom (Assistant Professor of Neurosurgery and Population Health Sciences) and Anoop Patel (Associate Professor of Neurosurgery, Biomedical Engineering, and Pathology. The Ostrom lab is focused
-
., D.V.M.) This position is Onsite. The work is performed on-site or at a designated assignment location. Be Bold. Help to operationalize NeoPBl/NeoSelect technology for the Klemen Lab. Assist in development
-
. Building on this work, we seek to harness the power of this new tool to optimize its therapeutic use for a wide variety of conditions including epilepsy, neuropsychiatric disease, movement disorders, chronic